Despite Ozempic being the most recognisable brand name, as far as the people prescribing it are concerned weight loss is ...

Fatty liver disease, also called metabolic dysfunction-associated steatohepatitis (MASH), is a condition where fat ...

The international study led by a Virginia Commonwealth University researcher found the medication semaglutide, commonly known ...

Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

While these injectable medications have gained in popularity for their dramatic effects, few people realise that your body ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A ...

A large trial showed that the weight-loss drug could reduce liver inflammation and scarring caused by a common condition.

The diabetes and weight loss drug semaglutide reversed liver scarring and inflammation. It’s among several drugs in the works for the condition MASH.

Wegovy and Ozempic are both semaglutide weight loss medications, but they’re prescribed differently based on who qualifies.

An analysis of emergency visits related to the active ingredient in drugs like Ozempic and Wegovy has exposed a surprising ...

Results showed that 62.9% of patients on Ozempic saw a reduction in liver inflammation, compared to 34.3% on placebo.

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...